... locally advanced non -small celllungcancer treated with concurrent chemotherapy and intensity-modulated radiotherapy RadiationOncology 2010, 5:35 Shi et al. RadiationOncology 2010, 5:35http://www.ro-journal.com/content/5/1/35Open ... Hominal S, Cordier JF, Carrie C: A prospective study on radiation pneumonitis following conformal radiation therapy in non -small- cell lung cancer: Clinical and dosimetric factors analysis. Radiother ... Dose-volume factors contributing to the incidence of radiation pneumonitis in non -small- celllungcancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol...
... morphological characteristics ofpermanent human smallcelllungcancercell lines. J Cancer Res ClinOncol 1987, 113:31-40.16. NCCN guidelines for small- celllung cancer. [http://www.nccn.org/professionals/physician_gls/f_guidelines.asp].17. ... limited-stage smallcelllung cancer. [http://clinicaltrials.gov/ct2/show/NCT00433563].27. Three different radiation therapy regimens in treating patients withlimited-stage smallcelllungcancer ... concurrent chemoradiation for limited smallcell lung cancer decreases survival and disease control. LungCancer 2001,33:249-258.26. Cisplatin, etoposide, and two different schedules of radiation...
... purposes) Radiation Oncology Open AccessResearchRadiotherapy quality assurance review in a multi-center randomized trial of limited-disease smallcelllung cancer: the Japan Clinical Oncology ... for Cancer Control and Information Services, National Cancer Center 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan and 3JCOG lungcancer study group, Thoracic Oncology Division, National Cancer ... limited-disease smallcelllung cancer. RTrequirements included a total dose of 45 Gy/30 fx (bis in die, BID/twice a day) withoutheterogeneity correction; elective nodal irradiation (ENI) of...
... Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:153-156.2. Non -small CellLungCancer Collaborative Group: Chemotherapyin non smallcelllung cancer: a meta-analysis ... docetaxel as first-line chemotherapy inpatients with advanced non -small celllung cancer: a lung cancer Galician group phase II study. Cancer Chemother Pharma-col 2007, 60:725-732.20. Binder D, ... cisplatin-teniposide in patients withadvanced non -small- celllung cancer. The European Organi-zation for Research and Treatment of CancerLung Cancer Cooperative Group. J Clin Oncol 1998, 16:2133-2141.7....
... Non -small- celllungcancer harbouring mutations in the EGFRkinase domain. Clin Transl Oncol 2010, 12:75-80.9. Gazdar AF: Activating and resistance mutations of EGFR in non -small- cell lung cancer: ... ofdetecting EGFR mutations in lungcancer patients.Methods: EGFR mutation status was analyzed by DNA assays, and compared with IHC results in five non -small- cell lungcancer (NSCLC) cell lines and tumor ... ofEGFR mutations in non -small- celllung cancer. Clin Cancer Res 2009,15:3023-3028.13. Motoi N, Szoke J, Riely GJ, Seshan VE, Kris MG, Rusch VW, Gerald WL,Travis WD: Lung adenocarcinoma: modification...
... are often dividedinto two broad categories: smallcelllungcancer (SCLC) and non -small celllungcancer (NSCLC). All majorhistological types of lungcancer are associated with smoking, although ... act as a risk marker of lungcancer in Taiwan. Cancer 2003,97:1558-1563.11. Klein F, Amin Kotb WF, Petersen I: Incidence of human papilloma virus in lung cancer. LungCancer 2009, 65:13-18.12. ... oesophagus, head andneck cancer. HPV has also been speculated to have a role in the pathogenesis of lung cancer. To validate thehypothesis of HPV involvement in smallcelllungcancer pathogenesis...
... marker expression in tumor cells versus stromal cells in non small celllung cancer. Clin Cancer Res 2007, 13:6649-57.24. World Health Organization: Histological Typing of Lung and PleuralTumours. ... innon -small celllung cancer. Clin Cancer Res 2008, 14:5220-7.30. Andersen S, Eilertsen M, Donnem T, et al: Diverging prognostic impacts ofhypoxic markers according to NSCLC histology. LungCancer ... Paclitaxel-carboplatin alone or withbevacizumab for non -small- celllung cancer. N Engl J Med 2006,355:2542-50.21. Besse B, Ropert S, Soria JC: Targeted therapies in lung cancer. Ann Oncol2007, 18(Suppl 9):ix135-ix142.22....
... Staging of small cell and non -small celllung cancer. University of Iowa Virtual Hos-pital; 1999. 6. Hopwood P, Stephens RJ: Symptoms at presentation for treat-ment in patients with lung cancer: ... breast cancer. Br J Cancer 2006,95(6):683-90.17. Cancer Research UK [http://www.cancerresearchuk.org]18. Cancer Help [http://www.cancerhelp.org.uk]19. Association for International Cancer ... Research and Treatment of Cancer Quality-of-Life Questionnaire -Lung Cancer- 17items; EQ-5D: EuroQoL-5 Dimensions; HRQL: Health-related Quality of Life; NSCLC: Non -Small CellLung Can-cer; SF-36:...
... gefitinib in non -small celllungcancer cell lines. Mol Cancer Res. 2006; 4(8): 521-8. 102. Taguchi F, Solomon B, Gregorc V, et al. Mass spectrometry to classify non -small- celllungcancer patients ... cause of cancer death world-wide (1). Lungcancer is generally classified into two histological types, smallcelllungcancer (SCLC) and non smallcelllungcancer (NSCLC). NSCLC accounts for ... in non -small cell lungcancer Is correlated with survival. Clin Cancer Res. 2001; 7(7): 1850-5. 93. Cappuzzo F, Gregorc V, Rossi E, et al. Gefitinib in pretreated non -small- celllung cancer...
... induced byfirst-line chemotherapy with single agentdocetaxel in a patient with advanced non small celllung cancer Ferdinando Riccardi1*, Giuseppe Di Lorenzo1, Carlo Buonerba1, Guglielmo Monaco2, ... Carteni’1AbstractBackground: Defining the optimal treatment for patients with inoperable non smallcelllungcancer (NSCLC),presenting with metastatic mediastinal lymph nodes, is challenging. Nevertheless, ... few cycles should notautomatically discourage to continue treatment.IntroductionIn non -small celllungcancer (NSCLC), mediastinallymphnode involvement comprises a wide spectrum ofseverity....
... non -small- cell lung cancer. Int J Radiat Oncol Biol Phys 2002, 52:382-389.16. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapyin treatment of stage I non -small celllung ... outcomes of stereotactic bodyradiotherapy for stage I non -small celllungcancer using differentdoses depending on tumor size. RadiationOncology 2010 5:81.Submit your next manuscript to BioMed ... RadiationOncology 2010, 5:81http://www.ro-journal.com/content/5/1/81Page 7 of 7 RESEARC H Open AccessClinical outcomes of stereotactic bodyradiotherapy for stage I non -small cell lung cancer...
... Stereotactic Body Rad iotherapy, Oligometastases, Non -Small CellLung Cancer BackgroundNon -small celllungcancer (NSCLC) is the leadingcause of cancer mortality in the United States [1].Patients ... RadiationOncology 2011, 6:80http://www.ro-journal.com/content/6/1/80Page 2 of 7 RESEARC H Open AccessComparison of outcomes in patients with stage IIIversus limited stage IV non -small cell ... smallcelllungcancer (NSCLC) includes palliative systemicchemotherapy and/or radiotherapy. Recent studies of patients with limited metastases treated with curative-intentstereotactic body radiation...
... for citation purposes) Radiation Oncology Open AccessStudy protocolRecommendations for implementing stereotactic radiotherapy in peripheral stage IA non -small celllung cancer: report from the ... surgery in patients withoperable lung cancer. A randomized phase III trial of Radiosurgery Or Surgeryfor operable Early stage (stage 1A) non -small cell Lung cancer (ROSEL, ClinicalTrials.gov ... radiotherapy for stage Inon -small celllung cancer. Radiother Oncol 2007, 85:429-434.39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat-eral primary lung cancers: the Indiana university...
... citation purposes) Radiation Oncology Open AccessResearchExclusion of elective nodal irradiation is associated with minimal elective nodal failure in non -small celllung cancer Erik P Sulman, ... atomic energy agency (IAEA)consultants' meeting on elective nodal irradiation in lung cancer: non -small celllungcancer (NSCLC). Int J Radiat OncolBiol Phys 2008, 72(2):335-342.6. Therasse ... RJ: Impact of FDG-PET on radiation ther-apy volume delineation in non -small- celllung cancer. Int JRadiat Oncol Biol Phys 2004, 59:78-86.3. Schild SE: Elective nodal irradiation (ENI) doesn't...
... for citation purposes) Radiation Oncology Open AccessResearchEvalution of surface-based deformable image registration for adaptive radiotherapy of non -small celllungcancer (NSCLC)Matthias ... for non -small- celllung cancer: obser-vations on tumor regression during treatment. Int J RadiatOncol Biol Phys 2005, 63:1024-1028.10. Yan D, Vicini F, Wong J, Martinez A: Adaptive radiation ... Philips RadiationOncology Systems, Fitchburg, WI, USA, is acknowledged.References1. Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M: Ster-eotactic radiotherapy for primary lung cancer...